Variability in hormone and growth factor receptor expression in primary versus recurrent, metastatic, and post-neoadjuvant breast carcinoma
MN Jabbour, CY Massad, FI Boulos - Breast cancer research and …, 2012 - Springer
The introduction of selective molecular targeted therapy, specifically tamoxifen and
trastuzumab, has significantly altered the clinical behavior of breast carcinoma. Several …
trastuzumab, has significantly altered the clinical behavior of breast carcinoma. Several …
Diffusion-weighted imaging in breast cancer: relationship between apparent diffusion coefficient and tumour aggressiveness
M Costantini, P Belli, P Rinaldi, E Bufi, G Giardina… - Clinical radiology, 2010 - Elsevier
AIM: To assess the utility of diffusion-weighted imaging in diagnosing and characterizing
breast malignancy. MATERIALS AND METHODS: From April 2006 to April 2009, all …
breast malignancy. MATERIALS AND METHODS: From April 2006 to April 2009, all …
Female breast cancer status according to ER, PR and HER2 expression: a population based analysis
A Caldarella, E Crocetti, S Bianchi, V Vezzosi… - Pathology & Oncology …, 2011 - Springer
The aim of this study is to evaluate the prognostic values of some biological parameters in a
population based series of female breast cancer patients. Through the Tuscan Cancer …
population based series of female breast cancer patients. Through the Tuscan Cancer …
Prevalence of molecular subtypes of invasive breast cancer: A retrospective study
N Kumar, P Patni, A Agarwal, MA Khan… - medical journal armed …, 2015 - Elsevier
Background Classification of breast cancers into different molecular subtypes using
immunohistochemistry as a surrogate tool to DNA microarray technology has been …
immunohistochemistry as a surrogate tool to DNA microarray technology has been …
[HTML][HTML] Glutathione and glutathione peroxidase expression in breast cancer: an immunohistochemical and molecular study
BV Jardim, MG Moschetta, C Leonel… - Oncology …, 2013 - spandidos-publications.com
The use of prognostic markers for breast cancer allows therapeutic strategies to be defined
more efficiently. The expression of glutathione (GSH) and glutathione peroxidase (GPX) in …
more efficiently. The expression of glutathione (GSH) and glutathione peroxidase (GPX) in …
Melatonin regulates tumor aggressiveness under acidosis condition in breast cancer cell lines
NM Sonehara, JZ Lacerda… - Oncology …, 2019 - spandidos-publications.com
Breast cancer progression is composed of multiple steps that are influenced by tumor cell
adaptations to survive under acidic conditions in the tumor microenvironment. Regulation of …
adaptations to survive under acidic conditions in the tumor microenvironment. Regulation of …
Diffusion magnetic resonance imaging in breast cancer characterisation: correlations between the apparent diffusion coefficient and major prognostic factors
P Belli, M Costantini, E Bufi, GG Giardina, P Rinaldi… - La radiologia …, 2015 - Springer
Purpose This study was done to investigate the correlation between the apparent diffusion
coefficient (ADC) and prognostic factors of breast cancer. Materials and methods From …
coefficient (ADC) and prognostic factors of breast cancer. Materials and methods From …
Immunochemistry for oestrogen receptor, progesterone receptor and HER2 on cell blocks in primary breast carcinoma
K Kumar S, N Gupta, A Rajwanshi, K Joshi… - …, 2012 - Wiley Online Library
K. Kumar S, N. Gupta, A. Rajwanshi, K. Joshi and G. Singh Immunochemistry for oestrogen
receptor, progesterone receptor and HER2 on cell blocks in primary breast carcinoma …
receptor, progesterone receptor and HER2 on cell blocks in primary breast carcinoma …
Distribution of breast cancer subtypes among Jordanian women and correlation with histopathological grade: molecular subclassification study
M Shomaf, J Masad, S Najjar, D Faydi - JRSM short reports, 2013 - journals.sagepub.com
Objective To evaluate the hormone receptor status and human epidermal growth factor
receptor 2 (HER2)/neu gene expression among Jordanian women with breast cancer. To …
receptor 2 (HER2)/neu gene expression among Jordanian women with breast cancer. To …
Potential candidate biomarkers for heterogeneity in triple-negative breast cancer (TNBC)
EY Cho, MH Chang, YL Choi, JE Lee, SJ Nam… - Cancer chemotherapy …, 2011 - Springer
Purpose Triple-negative breast cancer (TNBC) exhibits a distinct pattern of recurrence
characterized by a rapidly rising rate in the first 2 years with a peak at 2–3 years, followed by …
characterized by a rapidly rising rate in the first 2 years with a peak at 2–3 years, followed by …